PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Direxion Daily S&P Biotech Bear 3x Shares (LABD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISINUS25490K7458
CUSIP25490K745
IssuerDirexion
Inception DateMay 28, 2015
RegionNorth America (U.S.)
CategoryLeveraged Equities, Leveraged
Leveraged3x
Index TrackedS&P Biotechnology Select Industry Index (-300%)
Home Pagewww.direxion.com
Asset ClassEquity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

LABD has a high expense ratio of 1.06%, indicating higher-than-average management fees.


Expense ratio chart for LABD: current value at 1.06% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.06%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Direxion Daily S&P Biotech Bear 3x Shares

Popular comparisons: LABD vs. LABU, LABD vs. IBBQ, LABD vs. QQQ, LABD vs. SOXL, LABD vs. FNGD, LABD vs. TMV, LABD vs. XLV, LABD vs. KOLD, LABD vs. SPXU, LABD vs. VYM

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Direxion Daily S&P Biotech Bear 3x Shares, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%NovemberDecember2024FebruaryMarchApril
-99.87%
137.44%
LABD (Direxion Daily S&P Biotech Bear 3x Shares)
Benchmark (^GSPC)

S&P 500

Returns By Period

Direxion Daily S&P Biotech Bear 3x Shares had a return of 4.70% year-to-date (YTD) and -33.64% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date4.70%5.57%
1 month38.00%-4.16%
6 months-61.84%20.07%
1 year-33.64%20.82%
5 years (annualized)-52.47%11.56%
10 years (annualized)N/A10.37%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20243.51%-33.30%9.90%
202329.95%-36.65%-42.47%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of LABD is 7, indicating that it is in the bottom 7% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of LABD is 77
Direxion Daily S&P Biotech Bear 3x Shares(LABD)
The Sharpe Ratio Rank of LABD is 77Sharpe Ratio Rank
The Sortino Ratio Rank of LABD is 1111Sortino Ratio Rank
The Omega Ratio Rank of LABD is 1111Omega Ratio Rank
The Calmar Ratio Rank of LABD is 22Calmar Ratio Rank
The Martin Ratio Rank of LABD is 66Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


LABD
Sharpe ratio
The chart of Sharpe ratio for LABD, currently valued at -0.45, compared to the broader market-1.000.001.002.003.004.005.00-0.45
Sortino ratio
The chart of Sortino ratio for LABD, currently valued at -0.20, compared to the broader market-2.000.002.004.006.008.00-0.20
Omega ratio
The chart of Omega ratio for LABD, currently valued at 0.98, compared to the broader market0.501.001.502.002.500.98
Calmar ratio
The chart of Calmar ratio for LABD, currently valued at -0.38, compared to the broader market0.002.004.006.008.0010.0012.00-0.38
Martin ratio
The chart of Martin ratio for LABD, currently valued at -0.84, compared to the broader market0.0020.0040.0060.00-0.84
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.78, compared to the broader market-1.000.001.002.003.004.005.001.78
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.58, compared to the broader market-2.000.002.004.006.008.002.58
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.502.002.501.31
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.002.004.006.008.0010.0012.001.36
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 6.92, compared to the broader market0.0020.0040.0060.006.92

Sharpe Ratio

The current Direxion Daily S&P Biotech Bear 3x Shares Sharpe ratio is -0.45. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Direxion Daily S&P Biotech Bear 3x Shares with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.45
1.78
LABD (Direxion Daily S&P Biotech Bear 3x Shares)
Benchmark (^GSPC)

Dividends

Dividend History

Direxion Daily S&P Biotech Bear 3x Shares granted a 4.40% dividend yield in the last twelve months. The annual payout for that period amounted to $0.44 per share.


PeriodTTM202320222021202020192018
Dividend$0.44$0.59$0.09$0.00$1.00$4.33$6.83

Dividend yield

4.40%6.13%0.53%0.00%3.96%1.75%0.80%

Monthly Dividends

The table displays the monthly dividend distributions for Direxion Daily S&P Biotech Bear 3x Shares. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.00$0.07
2023$0.00$0.00$0.22$0.00$0.00$0.10$0.00$0.00$0.19$0.00$0.00$0.08
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.09
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$1.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$1.13$0.00$0.00$1.75$0.00$0.00$1.17$0.00$0.00$0.28
2018$0.80$0.00$0.00$0.49$0.00$0.00$1.72$0.00$0.00$3.83

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-99.94%
-4.16%
LABD (Direxion Daily S&P Biotech Bear 3x Shares)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Direxion Daily S&P Biotech Bear 3x Shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Direxion Daily S&P Biotech Bear 3x Shares was 99.97%, occurring on Feb 27, 2024. The portfolio has not yet recovered.

The current Direxion Daily S&P Biotech Bear 3x Shares drawdown is 99.94%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.97%Feb 12, 20162023Feb 27, 2024
-53.76%Sep 30, 201563Dec 29, 201513Jan 19, 201676
-41.58%Aug 25, 201517Sep 17, 20157Sep 28, 201524
-39.32%May 29, 201535Jul 17, 201524Aug 20, 201559
-14.71%Jan 20, 20163Jan 22, 20163Jan 27, 20166

Volatility

Volatility Chart

The current Direxion Daily S&P Biotech Bear 3x Shares volatility is 23.24%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%NovemberDecember2024FebruaryMarchApril
23.24%
3.95%
LABD (Direxion Daily S&P Biotech Bear 3x Shares)
Benchmark (^GSPC)